CSP
ELV icon

Cary Street Partners’s Elevance Health ELV Stock Holding History

Cary Street Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.61M Sell
4,151
-320
-7% -$119K 0.04% 404
2026
Q1 		$1.31M Buy
4,471
+985
+28% +$324K 0.03% 398
2025
Q4 		$1.22M Sell
3,486
-984
-22% -$333K 0.03% 405
2025
Q3 		$1.44M Sell
4,470
-3,724
-45% -$1.16M 0.04% 361
2025
Q2 		$3.19M Buy
8,194
+157
+2% +$63.1K 0.09% 234
2025
Q1 		$3.5M Sell
8,037
-635
-7% -$255K 0.11% 193
2024
Q4 		$3.2M Buy
+8,672
New +$3.63M 0.1% 196

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cary Street Partners's ELV Position: Q2 2026 in Review

Cary Street Partners reduced its Elevance Health (ELV) stake by 7.2% in Q2 2026, selling an estimated $119K and leaving 4,151 shares worth $1.61M. The position accounts for 0.04% of the portfolio, ranked #404.

Cary Street Partners first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.5M in Q1 2025. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Cary Street Partners held 4,151 shares of Elevance Health worth $1.61M as of Q2 2026.
  • Cary Street Partners sold 320 Elevance Health shares in Q2 2026, an estimated $119K.
  • Elevance Health made up 0.04% of Cary Street Partners's portfolio in Q2 2026, its #404 holding.
  • Cary Street Partners first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • Cary Street Partners's Elevance Health position peaked at $3.5M in Q1 2025.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.